Advanced search
Publication Cover
Journal of Microencapsulation
Micro and Nano Carriers
Volume 19, 2002 - Issue 1
Submit an article Journal homepage
127
Views
36
CrossRef citations to date
0
Altmetric
Research Article

Development of a new cyclosporine formulation based on poly(caprolactone) microspheres

M. R. Aberturas Dpto. Farmacia y Tecnologoaa Farmaceautica, Universidad de Alcala , Ctra. Madrid-Barcelona Km. 33,600, 28871 Alcalaa de Henares (Madrid), Spain
,
J. Molpeceres Dpto. Farmacia y Tecnologoaa Farmaceautica, Universidad de Alcala , Ctra. Madrid-Barcelona Km. 33,600, 28871 Alcalaa de Henares (Madrid), Spain
,
M. Guzmán Dpto. Farmacia y Tecnologoaa Farmaceautica, Universidad de Alcala , Ctra. Madrid-Barcelona Km. 33,600, 28871 Alcalaa de Henares (Madrid), Spain
&
F. García Dpto. Farmacia y Tecnologoaa Farmaceautica, Universidad de Alcala , Ctra. Madrid-Barcelona Km. 33,600, 28871 Alcalaa de Henares (Madrid), Spain
Pages 61-72 | Published online: 29 Sep 2008

  • BONDUELLE, S., CARRIER, M., PIMIENTA, C., BENOIT, J. P., and LENAERTS, V., 1996, Tissue concentration of nanoencapsulated radio-labelled cyclosporin following peroral delivery in mice or ophthalmic application in rabbits. European Journal of Pharmaceutics and Biopharmaceutics, 42, 313-319.
  • BRANNON-PEPPAS, L., 1995, Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery. International Journal of Pharmaceutics, 116,1-9.
  • CALVO, P., SANCHEZ, A., MARTINEZ, J., LOPEZ, M. I., CALONGE, M., PASTOR, J. C., and ALONSO, M. J., 1996, Polyester nanocapsules as new topical ocular delivery systems for cyclosporin A. Pharmaceutical Research, 13, 311-315.
  • CHA, Y., and PITT, C. G., 1988, A one-week subdermal delivery system for L-methadone based on biodegradable microcapsules. Journal of Controlled Release, 7, 69-78.
  • CHACON, M., BERGES, L., MOLPECERES, J., ABERTURAS, M. R., and GUZMAN, M., 1996, Optimized preparation of poly DL(lactic-glycolic) microspheres and nanoparticles for oral administration. International Journal of Pharmaceutics, 141, 81-91.
  • CHACON, M., MOLPECERES, J., BERGES, L., GUZMAN, M., and ABERTURAS, M. R., 1999, Stability and freeze-drying of cyclosporine loaded poly(D,L lactide-glycolide) carriers. European Journal of Pharmaceutical Sciences, 8, 99-107.
  • COFFIN, M. D., and McGINITY, J. W., 1992, Biodegradable pseudolatexes: the chemical stability of poly(D,L-lactide) and poly(e-caprolactone) nanoparticles in aqueous media. Pharmaceutical Research, 9, 200-205.
  • COUVREUR, P., and PUISIEUX, F., 1993, Nano- and micro-particles for the delivery of polypeptides and proteins. Advanced Drug Delivery Reviews, 10, 141-162.
  • CROWE, L. M., REID, D. S., and CROWE, J. H., 1996, Is trehalose special for preserving dry biomaterials? Biophysical Journal, 71, 2087-2093.
  • DE CHASTEIGNER, S., CAVE, G., FESSI, H., DEVISSAGUET, J. P., and PUISIEUX, F., 1996, Freeze-drying of itraconazole-loaded nanosphere suspensions: a feasability study. Drug Development and Research, 38, 116-124.
  • DE JAEGHERE, F., ALLÉMANN, E., LEROUX, J. C., STEVELS, W., FEIJEN, J., DOELKER, E., and GURNY, R., 1999, Formulation and lyoprotection of poly (lactic acid-co-ethylene oxide) nanoparticles: Influence on physical stability and in vitro cell uptake. Pharmaceutical Research, 16, 859-866.
  • ESQUISABEL, A., HERNANDEZ, R. M., IGARTUA, M., GASCÓN, A. R., CALVO, B., and PEDRAZ, J. L., 1997, Production of BCG alginate-PLL microcapsules by emulsification/internal gelation. Journal of Microencapsulation, 14, 627-638.
  • FAHR, A., 1993, Cyclosporin clinical pharmacokinetics. Clinical Pharmacokinetics, 24, 472-495.
  • FANG, J. Y., LIN, H. H., Hsu, L. R., and TSAI, Y. H., 1997, Characterization and stability of various liposome-encapsulated enoxacin formulations. Chemical and Pharmaceutical Bulletin, 45, 1504-1509.
  • FAULDS, D., GOA, K. L., and BENELD, P., 1993, Cyclosporin: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drugs, 45, 953-1040.
  • FLORENCE, A. T., 1997, The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual. Pharmaceutical Research, 14, 259-266.
  • GUTERRES, S. S., FESSI, H., BARRAT, G., DEVISSAGUET, J. P., and PUISIEUX, F., 1995, poly(oL-lactide) nanocapsules containing diclofenac: I. Formulation and stability study.International Journal of Pharmaceutics, 113, 57-63.
  • GUZMÁN, M., MOLPECERES, J., GARCIA, F., ABERTURAS, M. R., and RODRIGUEZ, M., 1993, Formation and characterization of cyclosporine-loaded nanoparticles. Journal of Pharmaceutical Sciences, 82, 498-502.
  • HINTZE, J. L., 1992, NCSS 5. X series, Utah, USA. LEMOINE, D., FRANCOIS, C., KEDZIEREWICZ, F., PREAT, V., HUFFMAN, M., and MAINCENT, P., 1996, Stability study of nanoparticles of poly(e-caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide). Biomaterials, 17, 2191-2197.
  • LIN, W. J., FLANAGAN, D. R., and LINHARDT, R. J., 1994, Accelerated degradation of polyfecaprolactone) by organic amines. Pharmaceutical Research, 11, 1030-1034.
  • MAULDING, H. V., TICE, T. R., COWSAR, D. R., FONG, J. W., PEARSON, J. E., and NAZARENO, J. P., 1986, Biodegradable microcapsules: acceleration of polymeric excipient hydrolytic rate by incorporation of a basic medicament. Journal of Controlled Release, 3, 103-117.
  • MOLPECERES, J., ABERTURAS, M. R., and GUZMAN, M., 2000, Biodegradable nanoparticles as a delivery system for cyclosporine: preparation and characterization. Journal of Microencapsulation, 17, 599-614.
  • OKADA, H., and TOGUCHI, H., 1995, Biodegradable microspheres in drug delivery. Critical Reviews on Therapuetic Drug Carrier Systems, 12, 1-99.
  • SANCHEZ, A., and ALONSO, M. J., 1995, Poly(D,L-Lactide-co-glycolide) micro and nanospheres as a way to prolong blood/plasma levels of subcutaneously injected cyclosporin A. European Journal of Pharmaceutics and Biopharmaceutics, 41, 27-37.
  • VERT, M., Li, S., and GARREAU, H., 1991, More about the degradation of LA/GA-derived matrices in aqueous media. Journal of Controlled Release, 16, 15-26.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.